Sol-Gel Technologies Ltd. Ordinary Shares (SLGL)

Price$77.98

Value ScoreD

Growth ScoreC

Momentum ScoreA

Favorite Metrics

Price vs S&P 500 (26W)75.92%

Price vs S&P 500 (4W)10.06%

VGM Score53.38

Market Capitalization$254.92M

All Metrics

P/CF (Annual)791.66x

Book Value / Share (Quarterly)$15.73

P/TBV (Annual)0.92x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)70.96%

Cash Flow / Share (Quarterly)$0.10

Price vs S&P 500 (YTD)76.89%

Net Profit Margin (TTM)-5.66%

EPS (TTM)$-0.35

10-Day Avg Trading Volume0.05M

EPS Excl Extra (TTM)$-0.35

Revenue Growth (5Y)17.19%

EPS (Annual)$-2.20

ROI (Annual)-26.86%

Net Profit Margin (5Y Avg)-450.06%

Cash / Share (Quarterly)$16.16

Revenue Growth QoQ (YoY)-89.52%

ROA (Last FY)-20.48%

Revenue Growth TTM (YoY)52.57%

EBITD / Share (TTM)$2.85

ROE (5Y Avg)-32.71%

Operating Margin (TTM)-12.59%

Cash Flow / Share (Annual)$0.10

P/B Ratio4.96x

P/B Ratio (Quarterly)5.00x

Net Income / Employee (Annual)$-218,800

EV / Revenue (TTM)13.26x

Net Interest Coverage (TTM)-1037.50x

ROA (TTM)-2.58%

EV / EBITDA (TTM)30.88x

EPS Incl Extra (Annual)$-2.20

Current Ratio (Annual)4.37x

Quick Ratio (Quarterly)8.54x

3-Month Avg Trading Volume0.04M

52-Week Price Return956.64%

EV / Free Cash Flow (Annual)890.11x

Revenue / Employee (TTM)$659,500

Tangible BV / Share (Quarterly)$1.74

P/S Ratio (Annual)13.15x

Asset Turnover (Annual)0.65x

52-Week High$97.97

Operating Margin (5Y Avg)-487.58%

EPS Excl Extra (Annual)$-2.20

CapEx CAGR (5Y)-36.35%

26-Week Price Return83.85%

Quick Ratio (Annual)4.21x

13-Week Price Return-1.29%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)8.84x

Enterprise Value$244.78M

Revenue / Share Growth (5Y)78.08%

Asset Turnover (TTM)0.45x

Book Value / Share Growth (5Y)26.85%

Revenue / Employee (Annual)$692,400

Pretax Margin (Annual)-31.60%

Cash / Share (Annual)$8.61

3-Month Return Std Dev101.43%

Net Income / Employee (TTM)$-37,400

ROE (Last FY)-26.86%

EPS Basic Excl Extra (Annual)$-2.20

Receivables Turnover (TTM)7.46x

EV / Free Cash Flow (TTM)890.11x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.35

Receivables Turnover (Annual)6.97x

ROI (TTM)-3.17%

P/S Ratio (TTM)13.81x

Pretax Margin (5Y Avg)-450.06%

Revenue / Share (Annual)$6.96

Tangible BV / Share (Annual)$1.83

Price vs S&P 500 (52W)932.27%

Year-to-Date Return85.05%

5-Day Price Return10.77%

EPS Normalized (Annual)$-2.20

ROA (5Y Avg)-27.50%

Net Profit Margin (Annual)-31.60%

Month-to-Date Return5.58%

EBITD / Share (Annual)$-2.67

Operating Margin (Annual)-38.88%

P/CF (TTM)791.66x

ROI (5Y Avg)-32.71%

EPS Basic Excl Extra (TTM)$-0.35

P/TBV (Quarterly)0.80x

P/B Ratio (Annual)5.15x

Pretax Margin (TTM)-5.66%

Book Value / Share (Annual)$8.19

Price vs S&P 500 (13W)-9.55%

Beta1.14x

P/FCF (Annual)926.97x

Revenue / Share (TTM)$6.51

ROE (TTM)-3.17%

52-Week Low$6.80

vGradeD

gGradeC

mGradeA

vgmGradeC

Show chart for

Earnings Surprise History

Q1 26-1.31est. -1.88

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.14

Industry Peers — Pharmaceuticals(550)

Symbol	Value Score	Growth Score	Momentum Score	Price
SLGLSol-Gel Technologies Ltd. Ordinary Shares	D	C	A	$77.98
LLYEli Lilly & Co.	D	B	B	$1131.42
JNJJohnson & Johnson	D	C	B	$232.77
ABBVABBVIE INC.	D	C	C	$227.23
MRKMerck & Co., Inc.	C	C	B	$120.79
NVSNovartis AG	C	C	C	$149.16
AZNAstraZeneca PLC	D	B	C	$185.95
NVONovo-Nordisk A/S	B	B	B	$42.96
ABTAbbott Laboratories	C	C	D	$91.07
PFEPfizer Inc.	B	C	C	$26.04
BMYBristol-Myers Squibb Co.	B	C	B	$57.27

About

Sol-Gel Technologies develops branded and generic topical pharmaceuticals for dermatology, with a focus on rare skin diseases. Its lead asset, SGT-610 (Patidegib Gel 2%), is a hedgehog pathway blocker targeting basal cell carcinoma prevention in Gorlin syndrome. The company also develops SGT-210 for rare keratosis-related indications such as Darier Disease, PC, PPK, and Olmsted.